Phenol For Pharmaceuticals & Agrochemicals

The industrial synthesis of acetylsalicylic acid begins with the carboxylation of sodium phenoxide under Kolbe–Schmitt conditions. Phenol is first neutralised with aqueous NaOH ( 50 wt% ) in a jacketed stainless-steel kneader, and the resulting sodium phenate solution is spray-dried to a free-flowing powder with residual moisture below 0.5 wt% . This dry phenate is charged into a vertical autoclave equipped with a multi-stage turbine agitator and heated to 125–130°C while pressurising with pre-dried carbon dioxide to 6–7 bar . The heterogeneous gas–solid reaction is exothermic; the temperature must remain within a ±3°C band to avoid the formation of para-hydroxybenzoic acid and dark tars. After 4–6 h , the dissolved sodium salicylate is transferred to a carbon-steel acidification vessel where sulfuric acid ( 98% ) is added until pH 2.5 is reached. The precipitated salicylic acid is centrifuged, washed with demineralised water to a chloride content below 50 ppm , and dried under vacuum at 60°C to yield a crystalline solid meeting the purity criterion of salicylic acid monograph Ph. Eur. 10.0 . Subsequent acetylation employs acetic anhydride at a molar ratio of 1:1.10 salicylic acid-to-anhydride; the reaction mass is held at 80–85°C in a glass-lined reactor with reflux. Unreacted anhydride and acetic acid are stripped under reduced pressure ( 50 mbar ), and the crude ester is recrystallised from a toluene–acetone mixture. The final product must satisfy USP-NF 2024 impurity criteria: free salicylic acid ≤ 0.05% , salicylic acid-related compound B ≤ 0.10% , and any unspecified impurity ≤ 0.05% . On a production-scale rotary vacuum dryer, batch-to-batch variance in free salicylic acid is typically ±0.008% when the acetylation temperature profile is controlled within the specified window. Deviation above 88°C triggers formation of 4-hydroxybenzoic acid acetyl ester that co-crystallises with the desired product and can only be removed by an additional reslurry step in isopropanol, lowering overall yield by 1.2–1.8% .

What mechanistic obstacles govern the nitration–reduction route to p-aminophenol?

One of the most stringent applications of phenol in the analgesic supply chain is conversion to p-aminophenol as the immediate precursor for paracetamol (acetaminophen). The two-step sequence starts with nitrosation of phenol with sodium nitrite in aqueous sulfuric acid at 0–5°C . The stoichiometric ratio of NaNO₂ to phenol is controlled at 1.05:1.0 ; excess nitrite must be kept below 2 mol% because residual nitrous acid catalyses oxidative coupling reactions that generate coloured quinone-imine oligomers during subsequent hydrogenation. The p-nitrosophenol wet cake is washed with chilled demineralised water until the conductivity of the filtrate falls below 200 µS/cm and then suspended in deionised water containing 0.5 wt% Raney nickel catalyst. Hydrogenation is conducted at 70–75°C and 0.8–1.0 MPa H₂ in a hastelloy C-22 stirred autoclave until hydrogen uptake ceases. The critical processing limit is the iron content of the isolated p-aminophenol: metal leached from the reactor walls and catalyst fines must be below 10 ppm Fe, otherwise the downstream acetylation with acetic anhydride yields a pink-coloured acetaminophen that fails the visual appearance test of Ph. Eur. monograph 0049 . After filtration of the catalyst, the solution is cooled to +2°C under nitrogen, and ascorbic acid is added at 0.02 wt% as an anti-oxidant. The p-aminophenol crystals are isolated by basket centrifugation, washed with ice-cold isopropanol, and dried in a vacuum paddle dryer at 45°C and 20 mbar absolute pressure. The dried product must contain less than 0.03% o-aminophenol and less than 0.01% 4,4′-diaminodiphenyl ether; these limits are verified by HPLC-UV at 254 nm against reference standards validated per ICH Q2(R2) . Production operators routinely observe that a pressure drop of 0.05 MPa across the hydrogenation catalyst filter indicates blinding by fine particles and necessitates an early batch termination to avoid catalyst breakdown and metal contamination.

Salicylic acid as a systemic acquired resistance elicitor in row crops

In agrochemical use, high-purity salicylic acid derived from phenol functions as a plant defence activator mimicking the endogenous signal molecule of the systemic acquired resistance pathway. The compound is applied as a foliar spray at concentrations between 0.5 mM and 2.0 mM in a formulation containing a non-ionic organosilicone surfactant at 0.1% v/v to enhance cuticle penetration. The salicylic acid employed must be essentially free of 4-hydroxybenzoic acid (≤ 0.01% ) because the latter acts as a competitive inhibitor of NPR1-mediated salicylic acid perception in dicotyledonous crops such as soybean and tomato. Industrial batches destined for this segment are recrystallised twice from ethanol–water ( 70:30 v/v ) and passed through a column of activated carbon to adsorb phenolic dimers; the final product typically shows a melting point of 158.5–159.0°C and a sulphated ash below 0.05% . Field trial data from maize production systems in Brazil indicate that a single application of 1.0 mM salicylic acid at the V6 growth stage reduces southern corn rust severity by 34–37% compared to untreated controls, though efficacy drops below 15% when tank-mixed with manganese-based foliar fertilisers because salicylic acid chelates Mn²⁺ and precipitates on leaf surfaces. Compatibility with copper oxychloride fungicides is also poor; jar tests show immediate flocculation at salicylic acid concentrations above 0.8 mM . Production-scale preparation of the commercial formulation involves dissolution of salicylic acid in propylene glycol at 60°C , followed by blending with a lignosulfonate dispersant and water to a final acid content of 100 g/L . The product label must comply with FAO Specification 110/SL (2006) for soluble concentrates and requires stability testing for 2 weeks at 54°C under accelerated storage conditions per CIPAC MT 46.3 .

When phenol is chlorinated to 2,4-dichlorophenol with molecular chlorine in a falling-film reactor

The phenoxy herbicide 2,4-dichlorophenoxyacetic acid is built on a 2,4-dichlorophenol intermediate derived from phenol. Continuous-flow falling-film chlorinators operating at 65–75°C are preferred over batch stirred tanks because they maintain a high interfacial area for chlorine absorption while minimising the liquid-phase residence time that leads to polychlorinated phenol by-products. The chlorine-to-phenol molar feed ratio is set at 2.02:1.00 ; the small stoichiometric excess compensates for chlorine lost to the off-gas stream, which is scrubbed with a 10% NaOH solution. A ferric chloride catalyst supported on activated alumina pellets is placed in the chlorinator’s recirculation loop at a loading of 0.5 wt% relative to phenol throughput. Under these conditions, the reaction mixture exits the falling-film unit with a composition of ~92% 2,4-dichlorophenol, ~5% 2,6-dichlorophenol, and ~3% 2,4,6-trichlorophenol. The crude 2,4-dichlorophenol is purified by fractional distillation in a packed column operating at a reflux ratio of 4:1 and a head pressure of 15 mbar ; the heart cut distilling at 107–109°C (at 15 mbar ) achieves a purity of >99.7% , as required for the subsequent condensation with sodium monochloroacetate. That condensation is carried out in an aqueous sodium hydroxide medium at 90–95°C and pH 10.5–11.0 ; the molar ratio of 2,4-dichlorophenol to monochloroacetic acid is 1.05:1.00 to drive the conversion to >99% . The 2,4-D sodium salt solution is acidified with HCl to pH 1.5 , and the free acid is filtered, washed, and dried to a moisture content below 0.5% . The finished product must comply with the FAO Specification 1/TC/S (1990) , which limits free phenol to ≤ 0.1% , dichlorophenol isomers to ≤ 30 g/kg , and the sum of chlorinated dioxins and furans (WHO-TEQ) to ≤ 10 pg/g . In factory-scale campaigns, the dioxin-forming potential is minimised by ensuring that the temperature in the chlorinator never exceeds 80°C and that the pH in the condensation reactor stays above 10.0 during the entire course of the reaction.Production of 4-hydroxycoumarin for anticoagulant rodenticides starts from phenol via a Michael addition–cyclisation pathway that demands rigorous exclusion of moisture in the early stages. Phenol is first acetylated in a solvent-free melt with acetyl chloride at 55–60°C to form phenyl acetate; the exotherm is moderated by controlled addition over 2.5 h to avoid runaway decomposition. The phenyl acetate is then subjected to Fries rearrangement by adding anhydrous aluminium chloride at a molar ratio of 1.10 mol AlCl₃ per mol ester and heating stepwise to 120°C then 180°C in a glass-lined reactor blanketed with dry nitrogen. The resulting o-hydroxyacetophenone is neutralised with ice-cold HCl, extracted into toluene, and distilled under reduced pressure (boiling point 96–98°C at 10 mbar ). Condensation with diethyl carbonate is catalysed by sodium ethoxide in absolute ethanol under anhydrous reflux for 8 h ; the intermediate ethyl 4-hydroxycoumarin-3-carboxylate precipitates upon cooling and is collected and subsequently hydrolysed in 10% NaOH at 85°C followed by acidification to yield 4-hydroxycoumarin. This key building block is then reacted with benzalacetone in a Michael addition to generate the warfarin precursor, which is isolated and condensed with an appropriate benzyl halide to yield second-generation anticoagulants such as brodifacoum and bromadiolone. In technical-grade rodenticide baits, the active ingredient is incorporated at 0.005–0.05% (w/w) onto whole wheat or paraffin blocks; the blend must pass a 72-hour acceptance feeding trial per EPA OPPTS 870.2100 guideline. Residual free phenol in the 4-hydroxycoumarin intermediate must be below 0.1% because even trace amounts trigger bait shyness in Rattus norvegicus, reducing palatability and field efficacy.

Stereospecific enzymatic resolution of DL-p-hydroxyphenylglycine and its impact on amoxicillin trihydrate yield

D-p-hydroxyphenylglycine serves as the chiral side chain in amoxicillin, and its synthesis from phenol proceeds via condensation with glyoxylic acid to give DL-p-hydroxymandelic acid, followed by reductive amination to DL-p-hydroxyphenylglycine. The glyoxylic acid consumed is used as a 50% aqueous solution, and the phenol-to-glyoxylic acid molar feed ratio is 1.0:0.95 ; the condensation is catalysed by a strong-acid ion-exchange resin (sulfonated polystyrene) in a fixed-bed column at 55°C with a liquid hourly space velocity of 0.8 h⁻¹ . The collected p-hydroxymandelic acid solution is neutralised with ammonia and hydrogenated over a Pd/C catalyst ( 5% Pd on carbon, 0.02 g Pd per g substrate ) at 60°C and 0.5 MPa hydrogen pressure. After catalyst removal, the DL-p-hydroxyphenylglycine is resolved enzymatically using D-hydantoinase coupled with a carbamoylase in a single-pot cascade at pH 8.5 and 40°C ; the L-isomer is racemised in situ by heating the mother liquor to 90°C in the presence of 0.1 M sodium acetate. The crystallised D-p-hydroxyphenylglycine is filtered, washed with methanol, and dried to a specific rotation of measured at 589 nm . For integration into amoxicillin, the Dane salt method is typically employed: the D-enantiomer is reacted with ethyl acetoacetate to form a protected amino acid, which is then mixed with 6-aminopenicillanic acid (6-APA) in a water–acetone mixture at 0–5°C in the presence of immobilised penicillin G acylase. The molar ratio of Dane salt to 6-APA is maintained at 1.05:1.00 . After enzymatic coupling, the amoxicillin trihydrate crystallises directly from the reaction medium upon adjusting the pH to 5.0 with ammonia; the crystal slurry is cooled to 2°C over 4 h to maximise the yield of the thermodynamically stable trihydrate form. The isolated bulk drug must meet Ph. Eur. 0260 limits for N,N-dimethylaniline (≤ 20 ppm ), residual acetone (≤ 5000 ppm ), and p-hydroxyphenylglycine-related substances (≤ 0.5% ). A common production bottleneck is the accumulation of D-p-hydroxyphenylglycine diketopiperazine in the mother liquor after more than 15 recycles ; once the diketopiperazine content exceeds 1.2% relative to the batch charge, crystal habit becomes acicular rather than the desired compact prismatic morphology, leading to poor filtration rates and clumping during storage.Methyl salicylate finds dual use as a topical analgesic base and as a pheromonal attractant in orchard pest management, with both applications demanding tightly controlled purity profiles. Esterification of salicylic acid with methanol is catalysed by concentrated sulfuric acid ( 0.5 wt% on salicylic acid) at reflux ( 64–66°C ) in a continuous reactive distillation column; the water–methanol azeotrope is drawn off overhead, and the methyl salicylate-rich bottom stream is neutralised with sodium carbonate, washed with water, and fractionated under vacuum. The pharmacopoeial grade must comply with USP-NF 2024 , which specifies a GC assay of 98.0–102.0% , a limit of free salicylic acid ≤ 0.02% , and a refractive index at 20°C of 1.535–1.538 . For insect-trap formulations, methyl salicylate is blended with eugenol and geraniol at typical ratios of 5:2:1 by weight to mimic the volatile bouquet of damaged host plants, attracting tephritid fruit flies and certain scolytid beetles. The formulation is absorbed onto a polymeric slow-release dispenser that delivers 0.5–2.0 mg of methyl salicylate per day at field temperatures between 15°C and 35°C . Regulatory compliance for the semiochemical application falls under EPA 40 CFR Part 152 as a minimum-risk pesticide when used in traps; the sum of non-volatile residues after 100°C gravimetric analysis must be ≤ 0.1% to prevent dispenser clogging. In production practice, the vacuum fractionation column requires a bottom temperature no higher than 110°C at 10 mbar to avoid thermal decarboxylation of residual salicylic acid back to phenol, which would introduce a fishy odour detectable by gas chromatography–olfactometry even at 0.5 ppm in the final product.

Catalytic hydroxylation of phenol to catechol for carbofuran synthesis: hydrogen peroxide efficiency and tar mitigation

Integration of phenol into the N-methylcarbamate insecticide supply chain proceeds through catechol as the pivotal dihydroxy intermediate. The direct hydroxylation of phenol with hydrogen peroxide ( 30% aqueous) is conducted over a titanium silicalite-1 (TS-1) catalyst in a slurry reactor at 80°C and a reaction pH of 4.5 , maintained by continuous addition of dilute sodium acetate buffer. A molar H₂O₂-to-phenol ratio of 0.35:1.00 is employed to suppress over-oxidation; under optimised conditions, phenol conversion reaches 32–35% per pass with a catechol selectivity of 78–82% and a hydroquinone co-product selectivity of 15–18% . The crude mixture is extracted with methyl isobutyl ketone and separated by sequential fractional crystallisation: hydroquinone crystallises first at –5°C and is removed, followed by catechol recovery as the temperature is lowered to –15°C . Catechol intended for carbofuran production must contain less than 0.2% hydroquinone because the latter participates in competing side reactions during the subsequent condensation with methyl isocyanate, forming coloured quinoid polymers that darken the final technical concentrate. The condensation step reacts catechol with methyl isocyanate in a xylene solvent at 60–65°C in the presence of triethylamine catalyst ( 0.5 mol% on catechol); the resulting 2,3-dihydro-2,2-dimethylbenzofuran-7-ol intermediate is then carbamoylated in a second methyl isocyanate addition at 80°C to form carbofuran. The technical-grade insecticide must meet FAO Specification 138/TC (2007) , which requires a carbofuran content of ≥ 970 g/kg , free catechol ≤ 0.5 g/kg , and a maximum of 1 g/kg of bis-chloromethyl ether when hypochlorite-containing water is used in downstream processing. A critical operational hazard arises from the accumulation of methyl isocyanate oligomers in the condenser vent line; these must be purged with hot nitrogen every 48 h to prevent complete blockage, a procedure documented in plant operating logs to reduce downtime from 4.5 h to 1.2 h per cleaning cycle.

Comparative impurity profiles of phenol-derived salicylic acid across major pharmacopoeial standards

Impurity parameter	Ph. Eur. 10.0 (Salicylic acid monograph)	USP-NF 2024	ChP 2020
Free phenol	≤ 0.02%	≤ 0.02%	≤ 0.02%
4-Hydroxybenzoic acid	≤ 0.10%	≤ 0.10%	≤ 0.05%
4-Hydroxyisophthalic acid	≤ 0.10%	Not specified	Not specified
Chloride (as Cl)	≤ 50 ppm	≤ 100 ppm	≤ 50 ppm
Sulphated ash	≤ 0.10%	≤ 0.10%	≤ 0.10%
Loss on drying	≤ 0.50%	≤ 0.50%	≤ 0.50%

In many production facilities, the salicylic acid intended for both pharmaceutical acetylation and agrochemical elicitor use is produced in campaign lots sharing the same train. When switching from a USP-grade campaign to a technical-grade stream, a documented purging protocol with refluxing ethanol must be executed for 3 h to eliminate cross-contamination from the 4-hydroxybenzoic acid-enriched heel that accumulates in the crystalliser drain lines. Operators validate cleaning efficacy by collecting a heel rinse sample and demonstrating that the 272 nm absorbance in a 1 cm cell is below 0.010 AU against a blank of the fresh solvent.

Key process thresholds for 2,4-dichlorophenol manufacture from phenol

Parameter	Setpoint / range	Consequence of deviation
Chlorination temperature	65–75°C	Temperature > 80°C increases polychlorinated dioxin formation rate by factor ~3.2
Cl₂:phenol molar ratio	2.02:1.00	Ratio exceeding 2.10 elevates 2,4,6-trichlorophenol above 5% in crude
Neutralisation pH in condensation	10.5–11.0	pH below 10.0 for > 10 min triggers formation of 2,4-dichlorophenyl monochloroacetate; pH above 11.5 degrades monochloroacetate to glycolate
Vacuum distillation head pressure	15 mbar	Pressure above 25 mbar shifts boiling point such that 2,6-dichlorophenol contaminates the heart cut
Dioxin TEQ in final product	≤ 10 pg/g	Non-compliance triggers batch rejection per FAO 1/TC/S